Optimizing Brain Excitability for Major Depression

Optimizing Brain Excitability in Depression

Recruiting N/A Interventional Study
Major Depressive Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
145 (estimated)
Sponsor
Stanford University · Other
Who this trial is looking for

This trial is looking for men and women aged 18 to 65 who have major depressive disorder. Participants will help improve treatments for depression by taking part in brain activity tests and monitoring.

Are You a Good Fit for This Trial?
Must not be taking OlanzapineChlorpromazineLithium
Rules you out Neurological disorderSeizure disorderPsychotic disorderBipolar disorder

You may be able to join if

  • I am between 18 and 65 years old.
  • I have been diagnosed with major depressive disorder.
  • I am currently in a depressive episode.
  • I have moderate-to-severe depression.
  • I understand English well.
  • I have no current or past neurological disorders.
  • I do not have a seizure disorder.
  • I have the capacity to consent to the study.

You may not be able to join if

  • I have a contraindication for MRIs.
  • I have had head trauma with loss of consciousness.
  • I have a history of seizures.
  • I have an uncontrolled medical disease.
  • I have an unstable medical condition.
  • I am currently abusing substances.
  • I have a diagnosis of psychotic or bipolar disorder.
  • I am pregnant or breastfeeding.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The goal of this study is to improve depression treatment by establishing reliable prefrontal excitability markers through Targeting with Automated Real-time Guidance for Enhancing TEPs (TARGET).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Men and women, ages 18 to 65 * Diagnosis of major depressive disorder, assessed through a Structured Clinical Interview for DSM-5 (SCID-5) * In a current depressive episode, assessed through a Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disord…
Contacts

Jade T Truong, BS

408-840-3313

kellerlab@stanford.edu

CONTACT